These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 31492037)
1. In Vivo Anti-Tumor Effects of Citral on 4T1 Breast Cancer Cells via Induction of Apoptosis and Downregulation of Aldehyde Dehydrogenase Activity. Nigjeh SE; Yeap SK; Nordin N; Rahman H; Rosli R Molecules; 2019 Sep; 24(18):. PubMed ID: 31492037 [TBL] [Abstract][Full Text] [Related]
2. Antitumor and Anti-Metastatic Effects of Citral-Loaded Nanostructured Lipid Carrier in 4T1-Induced Breast Cancer Mouse Model. Nordin N; Yeap SK; Rahman HS; Zamberi NR; Mohamad NE; Abu N; Masarudin MJ; Abdullah R; Alitheen NB Molecules; 2020 Jun; 25(11):. PubMed ID: 32526880 [TBL] [Abstract][Full Text] [Related]
3. Citral reduces breast tumor growth by inhibiting the cancer stem cell marker ALDH1A3. Thomas ML; de Antueno R; Coyle KM; Sultan M; Cruickshank BM; Giacomantonio MA; Giacomantonio CA; Duncan R; Marcato P Mol Oncol; 2016 Nov; 10(9):1485-1496. PubMed ID: 27592281 [TBL] [Abstract][Full Text] [Related]
5. In vitro cytotoxicity and anticancer effects of citral nanostructured lipid carrier on MDA MBA-231 human breast cancer cells. Nordin N; Yeap SK; Rahman HS; Zamberi NR; Abu N; Mohamad NE; How CW; Masarudin MJ; Abdullah R; Alitheen NB Sci Rep; 2019 Feb; 9(1):1614. PubMed ID: 30733560 [TBL] [Abstract][Full Text] [Related]
6. High aldehyde dehydrogenase activity enhances stem cell features in breast cancer cells by activating hypoxia-inducible factor-2α. Kim RJ; Park JR; Roh KJ; Choi AR; Kim SR; Kim PH; Yu JH; Lee JW; Ahn SH; Gong G; Hwang JW; Kang KS; Kong G; Sheen YY; Nam JS Cancer Lett; 2013 Jun; 333(1):18-31. PubMed ID: 23174107 [TBL] [Abstract][Full Text] [Related]
7. Optimized Dosing Schedule Based on Circadian Dynamics of Mouse Breast Cancer Stem Cells Improves the Antitumor Effects of Aldehyde Dehydrogenase Inhibitor. Matsunaga N; Ogino T; Hara Y; Tanaka T; Koyanagi S; Ohdo S Cancer Res; 2018 Jul; 78(13):3698-3708. PubMed ID: 29735553 [TBL] [Abstract][Full Text] [Related]
8. Formulation, Characterization, and Antitumor Properties of Trans- and Cis-Citral in the 4T1 Breast Cancer Xenograft Mouse Model. Zeng S; Kapur A; Patankar MS; Xiong MP Pharm Res; 2015 Aug; 32(8):2548-58. PubMed ID: 25673043 [TBL] [Abstract][Full Text] [Related]
9. Targeting aberrant expression of Notch-1 in ALDH Pal D; Kolluru V; Chandrasekaran B; Baby BV; Aman M; Suman S; Sirimulla S; Sanders MA; Alatassi H; Ankem MK; Damodaran C Mol Carcinog; 2017 Mar; 56(3):1127-1136. PubMed ID: 27753148 [TBL] [Abstract][Full Text] [Related]
10. Citral in lemon myrtle, lemongrass, litsea, and melissa essential oils suppress the growth and invasion of breast cancer cells. Nagata T; Satou T; Hayashi S; Satyal P; Watanabe M; Riggs B; Saida Y BMC Complement Med Ther; 2024 Jun; 24(1):211. PubMed ID: 38831283 [TBL] [Abstract][Full Text] [Related]
11. Doxorubicin-enriched, ALDH(br) mouse breast cancer stem cells are treatable to oncolytic herpes simplex virus type 1. Zhuang X; Zhang W; Chen Y; Han X; Li J; Zhang Y; Zhang Y; Zhang S; Liu B BMC Cancer; 2012 Nov; 12():549. PubMed ID: 23176143 [TBL] [Abstract][Full Text] [Related]
12. Murine breast carcinoma 4T1 cells are more sensitive to atranorin than normal epithelial NMuMG cells in vitro: Anticancer and hepatoprotective effects of atranorin in vivo. Solár P; Hrčková G; Koptašíková L; Velebný S; Solárová Z; Bačkor M Chem Biol Interact; 2016 Apr; 250():27-37. PubMed ID: 26969521 [TBL] [Abstract][Full Text] [Related]
13. Antitumor and antimetastatic activities of chloroquine diphosphate in a murine model of breast cancer. Jiang PD; Zhao YL; Deng XQ; Mao YQ; Shi W; Tang QQ; Li ZG; Zheng YZ; Yang SY; Wei YQ Biomed Pharmacother; 2010 Nov; 64(9):609-14. PubMed ID: 20888174 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the efficacy of alginate nanoparticles containing Cymbopogon citratus essential oil and citral on melanoma and breast cancer cell lines under normoxic and hypoxic conditions. Karami F; Osanloo M; Alipanah H; Zarenezhad E; Moghimi F; Ghanbariasad A BMC Complement Med Ther; 2024 Oct; 24(1):372. PubMed ID: 39427126 [TBL] [Abstract][Full Text] [Related]
15. Subchronic toxicity, immunoregulation and anti-breast tumor effect of Nordamnacantal, an anthraquinone extracted from the stems of Morinda citrifolia L. Abu N; Zamberi NR; Yeap SK; Nordin N; Mohamad NE; Romli MF; Rasol NE; Subramani T; Ismail NH; Alitheen NB BMC Complement Altern Med; 2018 Jan; 18(1):31. PubMed ID: 29374471 [TBL] [Abstract][Full Text] [Related]
16. Yulangsan polysaccharide inhibits 4T1 breast cancer cell proliferation and induces apoptosis in vitro and in vivo. Qin N; Lu S; Chen N; Chen C; Xie Q; Wei X; Ye F; He J; Li Y; Chen L; Jiang L; Lu X; Yuan Y; Li J; Jiao Y; Huang R Int J Biol Macromol; 2019 Jan; 121():971-980. PubMed ID: 30340007 [TBL] [Abstract][Full Text] [Related]
17. Interferon-gamma inhibits aldehyde dehydrogenasebright cancer stem cells in the 4T1 mouse model of breast cancer. Zhuang X; Shi G; Hu X; Wang H; Sun W; Wu Y Chin Med J (Engl); 2021 Dec; 135(2):194-204. PubMed ID: 34890380 [TBL] [Abstract][Full Text] [Related]
18. The metabolism of 3,7-dimethyl-2,6-octadienal (citral) in rat hepatic mitochondrial and cytosolic fractions. Interactions with aldehyde and alcohol dehydrogenases. Boyer CS; Petersen DR Drug Metab Dispos; 1991; 19(1):81-6. PubMed ID: 1673427 [TBL] [Abstract][Full Text] [Related]
19. [Study on mechanism of inhibiting proliferation of head and neck cancer cells by citral, active ingredient of lemon essential oil]. Chen L; Zhang YJ; Qin HW; Hu WJ; Liu YJ; Xiao GS; DU HH; Yang DL Zhongguo Zhong Yao Za Zhi; 2024 May; 49(9):2364-2375. PubMed ID: 38812137 [TBL] [Abstract][Full Text] [Related]
20. Crosstalk between aldehyde dehydrogenase-1 and chemoresistance in breast cancer: Insights into the role of vitamin D3. Attia YM; Hammam OA; Ammar RA; Mansour MT; Elmazar MM Life Sci; 2020 Jul; 253():117733. PubMed ID: 32360127 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]